Permethrin-treated Baby-wraps for the Prevention of Malaria in Children

NCT05391230 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-07-14

No results posted yet for this study

Summary

The scientific objective of this study is to test the protective effect of permethrin-treated lesus against P. falciparum malaria in infants and young children.

Conditions

Interventions

OTHER

Permethrin-treated lesu

0.5% permethrin soaked baby wraps (lesus)

OTHER

Untreated lesu

Water soaked baby wraps (lesus)

Sponsors & Collaborators

  • Doris Duke Charitable Foundation

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Ross Boyce, MD, Msc · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-03
Primary Completion
2024-10-19
Completion
2024-11-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05391230 on ClinicalTrials.gov